Skip to main content

Table 3 Symptoms of COVID-19 in Toxoplasma-infected and Toxoplasma-free participants

From: Toxoplasmosis is a risk factor for acquiring SARS-CoV-2 infection and a severe course of COVID-19 in the Czech and Slovak population: a preregistered exploratory internet cross-sectional study

 

All

Women

Men

OR

    
 

Toxo−

Toxo+

Toxo−

Toxo+

Toxo−

Toxo+

CI95

P

ORW

ORM

Fever > 38 °C (100.4 °F)

0.38

0.39

0.34

0.37

0.47

0.45

1.07

0.67–1.7

0.789

1.09

0.99

Fatigue

0.74

0.81

0.79

0.90

0.57

0.57

1.19

0.45–3.14

0.729

1.30

1.22

Dry cough

0.42

0.53

0.44

0.50

0.38

0.64

1.40

0.89–2.2

0.141

1.16

2.97

Shortness of breath

0.32

0.39

0.33

0.41

0.31

0.32

1.19

0.74–1.91

0.466

1.30

1.04

Sore throat

0.36

0.36

0.37

0.40

0.34

0.23

1.00

0.63–1.61

0.985

1.08

1.36

Headache

0.70

0.78

0.74

0.84

0.60

0.59

1.37

0.82–2.29

0.225

1.71

0.90

Chest pain or pressure

0.32

0.51

0.35

0.53

0.24

0.45

1.96

1.24–3.13

0.004

1.79

2.73

Other pains

0.31

0.38

0.33

0.41

0.26

0.27

1.20

0.74–1.93

0.453

1.16

1.18

Diarrhoea

0.28

0.36

0.29

0.36

0.25

0.36

1.40

0.86–2.26

0.171

1.17

2.26

Conjunctivitis

0.08

0.12

0.09

0.14

0.05

0.05

1.28

0.6–2.72

0.522

1.22

1.84

Loss of smell

0.71

0.72

0.73

0.74

0.66

0.64

0.99

0.61–1.59

0.954

0.99

0.94

Loss of taste

0.58

0.55

0.62

0.59

0.49

0.45

0.88

0.56–1.39

0.593

0.89

0.87

Middle ear pain

0.12

0.22

0.14

0.25

0.06

0.14

1.95

0.68–5.56

0.209

1.67

5.11

Problems speaking and walking

0.03

0.05

0.03

0.06

0.04

0.05

1.72

0.6–4.98

0.313

1.32

2.18

Skin rash

0.08

0.10

0.10

0.09

0.02

0.14

1.31

0.6–2.87

0.492

0.77

6.00

Changes in pigmentation

0.03

0.05

0.04

0.06

0.01

0.05

1.81

0.64–5.09

0.262

1.29

4.05

Higher sexual desire

0.03

0.08

0.03

0.06

0.04

0.14

3.40

1.42–8.17

0.006

2.53

4.50

Other symptoms

0.27

0.25

0.29

0.27

0.22

0.18

0.93

0.56–1.55

0.778

0.90

0.99

  1. Columns 2–7 show the reported incidence of particular symptoms (in percentages); the last five columns show the results of logistic regression with a particular symptom as the dependent variable; age, sex, and size of place of residence as covariates; and toxoplasmosis as the independent variable. The last two columns show the odds ratio computed separately for women (ORW) and men (ORM). The results in bold were significant after correction for multiple tests